Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enovix | ENVX | Nov 15, 2024 | 8.48 | -4.18 |
Enphase Energy | ENPH | Nov 15, 2024 | 59.52 | -6.36 |
Enpro | NPO | Nov 15, 2024 | 165.78 | +1.31 |
Enservco | ENSV | Nov 15, 2024 | 0.06 | -3.33 |
Enstar Group | ESGR | Nov 15, 2024 | 323.71 | +0.06 |
Enstar Group Depository E Pref | ESGRO | Nov 15, 2024 | 20.23 | -2.86 |
Enstar Pref | ESGRP | Nov 15, 2024 | 20.22 | -3.16 |
Ensysce Biosciences | ENSC | Nov 15, 2024 | 0.67 | +5.46 |
Entegris | ENTG | Nov 15, 2024 | 97.67 | -3.77 |
Entera Bio | ENTX | Nov 15, 2024 | 1.73 | -2.81 |
Entergy | ETR | Nov 15, 2024 | 149.12 | +1.41 |
Entergy Texas A Pref | ETI- | Nov 15, 2024 | 24.50 | +0.12 |
Entergy Utility Enterprises | EMP | Nov 15, 2024 | 21.90 | -0.45 |
Entero Therapeutics | ENTO | Nov 15, 2024 | 0.49 | -6.06 |
Enterprise Bancorp | EBTC | Nov 15, 2024 | 36.65 | -1.24 |
Enterprise Financial Services | EFSC | Nov 15, 2024 | 58.83 | -0.42 |
Enterprise Financial Services A Pref | EFSCP | Nov 15, 2024 | 20.70 | +0.34 |
Enterprise Products Partners LP Unit | EPD | Nov 15, 2024 | 31.09 | +0.91 |
Entrada Therapeutics | TRDA | Nov 15, 2024 | 17.85 | -6.25 |
Entravision Communications | EVC | Nov 15, 2024 | 2.57 | -0.39 |
Envela | ELA | Nov 15, 2024 | 6.24 | 0.00 |
Enveric Biosciences | ENVB | Nov 15, 2024 | 0.36 | -8.06 |
Envestnet | ENV | Nov 15, 2024 | 62.94 | -0.03 |
Enviri | NVRI | Nov 15, 2024 | 6.85 | -2.56 |
Environmental Svcs ETF Market Vectors | EVX | Nov 15, 2024 | 183.52 | -0.61 |
Envirotech Vehicles | EVTV | Nov 15, 2024 | 1.71 | +0.59 |
Envista | NVST | Nov 15, 2024 | 20.57 | +2.44 |
Envoy Medical A | COCH | Nov 15, 2024 | 2.14 | +0.47 |
enVVeno Medical | NVNO | Nov 15, 2024 | 3.28 | -3.81 |
Enzo Biochem | ENZ | Nov 15, 2024 | 1.04 | -8.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.